Hikma Pharmaceuticals Plc Block listing Interim Review (6144J)
14 Aprile 2020 - 3:30PM
UK Regulatory
TIDMHIK
RNS Number : 6144J
Hikma Pharmaceuticals Plc
14 April 2020
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
-------------------------------------------------------------
Period of return From: 1 October 2019 To: 31 March 2020
------------------ -------------------------- -------- -----------------------
Balance of unallotted securities under scheme(s) from SOP: 792,700 ordinary shares of 10 pence
previous return:
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been SOP: 0 ordinary shares of 10 pence
increased since the date of the last
return (if any increase has been applied for):
-------------------------------------------------------------
Less: Number of securities issued/allotted under SOP: 0 ordinary shares of 10 pence
scheme(s) during period (see LR3.5.7G):
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet SOP: 792,700 ordinary shares of 10 pence
issued/allotted at end of period:
-------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
--------------------------------------------------------------------
Period of return From: 1 October 2019 To: 31 March 2020
------------------ ---------------------------- ---------- --------------------------
Balance of unallotted securities under LTIP: 102,714 ordinary shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) LTIP: 0 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted LTIP: 15,014 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet LTIP: 87,700 ordinary shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
--------------------------------------------------------------------
Period of return From: 1 October 2019 To: 31 March 2020
------------------ ---------------------------- ---------- --------------------------
Balance of unallotted securities under MIP: 770,393 ordinary shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) MIP: 1,000,000 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted MIP: 8,391 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet MIP: 1,519,989 ordinary shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 14 April 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
--------------------------------------------------------------------
Period of return From: 1 October 2019 To: 31 March 2020
------------------ ----------------------------- --------- --------------------------
Balance of unallotted securities under EIP: 1,541,128 ordinary shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) EIP: 0 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted EIP: 8,742 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet EIP: 1,102,558 ordinary shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BLRGPUBPCUPUGWC
(END) Dow Jones Newswires
April 14, 2020 09:30 ET (13:30 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024
